Clarapath

Executive Summary

Clarapath is a privately held medical robotics company founded in 2014 and headquartered in Hawthorne, New York. The company develops automated laboratory systems for histology, with its flagship product, the SectionStar, a benchtop robotic system designed to automate tissue sectioning and slide preparation. By leveraging robotics and AI/machine learning, Clarapath aims to improve efficiency, slide quality, and data capture in pathology labs, addressing a critical bottleneck in diagnostic workflows. The company operates at the intersection of diagnostics and AI, serving a growing demand for automation in clinical laboratories. The market for histology automation is expanding as laboratories face increasing sample volumes and a shortage of skilled histotechnologists. Clarapath's SectionStar has the potential to reduce manual labor, standardize slide quality, and integrate with laboratory information systems, thereby enhancing throughput and accuracy. While the company has not disclosed funding or revenue, its focus on a clear unmet need positions it well for adoption in hospital and reference labs. If successful, Clarapath could become a key player in the digital pathology ecosystem, enabling faster and more reliable diagnoses.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for SectionStar60% success
• Q4 2026First Commercial Installation at a Major Hospital Network50% success
• H2 2026Series B Funding Round70% success